2024 Q4 Form 10-Q Financial Statement

#000147793224008353 Filed on December 27, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $116.8K $176.0K
YoY Change -33.65% 2080.53%
% of Gross Profit
Research & Development $0.00 $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $723.9K $584.9K
YoY Change 23.77% 7147.58%
Operating Profit -$723.9K -$584.9K
YoY Change 23.77% 7147.58%
Interest Expense $20.76K $14.11K
YoY Change 47.12% 25.64%
% of Operating Profit
Other Income/Expense, Net -$24.83K $14.11K
YoY Change -276.01% 25.64%
Pretax Income -$748.8K -$599.0K
YoY Change 25.0% 7322.4%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$748.8K -$599.0K
YoY Change 25.0% 7322.4%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 208.5M shares 208.0M shares 202.7M shares
Diluted Shares Outstanding 208.4M shares 202.8M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $6.866K $9.996K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $69.27K $63.38K
YoY Change 9.3% 1728.12%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $123.5K $6.430K
YoY Change 1820.73% 6330.0%
TOTAL ASSETS
Total Short-Term Assets $69.27K $63.38K
Total Long-Term Assets $123.5K $6.430K
Total Assets $192.8K $69.81K
YoY Change 176.14% 1857.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.194M $3.158M
YoY Change 96.16% 1878.55%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.194M $3.158M
Total Long-Term Liabilities
Total Liabilities $6.194M $3.158M
YoY Change 96.16% 1878.55%
SHAREHOLDERS EQUITY
Retained Earnings -$12.45M -$8.373M
YoY Change 48.69% 62.44%
Common Stock $20.85K $20.28K
YoY Change 2.81% 2554.19%
Preferred Stock
YoY Change
Treasury Stock (at cost) $52.95K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$6.001M -$3.088M
YoY Change
Total Liabilities & Shareholders Equity $192.8K $69.81K
YoY Change 176.14% 1857.13%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$748.8K -$599.0K
YoY Change 25.0% 7322.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6866 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
100 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
100 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
347406 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6194079 usd
CY2024Q3 us-gaap Liabilities
Liabilities
6194079 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
208484211 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
202784211 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
20848 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6647575 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-166685 usd
CY2024Q3 pvnc Goods And Service Tax Receivable Current
GoodsAndServiceTaxReceivableCurrent
39268 usd
CY2023Q4 pvnc Goods And Service Tax Receivable Current
GoodsAndServiceTaxReceivableCurrent
61798 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23039 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6812 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
69273 usd
CY2023Q4 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
0 usd
CY2024Q3 us-gaap Assets
Assets
192776 usd
CY2023Q4 us-gaap Assets
Assets
69383 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2308740 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2464558 usd
CY2024Q3 pvnc Due To Related Party Current
DueToRelatedPartyCurrent
4999 usd
CY2023Q4 pvnc Due To Related Party Current
DueToRelatedPartyCurrent
4999 usd
CY2024Q3 us-gaap Loans Payable
LoansPayable
3390044 usd
CY2023Q4 us-gaap Loans Payable
LoansPayable
2720549 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
142890 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
77964 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5376557 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
20278 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5223245 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-60130 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
69383 usd
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
0 usd
CY2024Q3 us-gaap Notes Receivable Net
NotesReceivableNet
80000 usd
CY2024Q3 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
1990 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
108487 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5376557 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
52954 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
52954 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12450087 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10437613 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-6001303 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5307174 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
192776 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69383 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
242927 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
546019 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
631437 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
421759 usd
us-gaap Professional Fees
ProfessionalFees
1528580 usd
us-gaap Professional Fees
ProfessionalFees
507785 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
116760 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
175969 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
527792 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
435597 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
655000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
584917 usd
us-gaap Operating Expenses
OperatingExpenses
2602391 usd
us-gaap Operating Expenses
OperatingExpenses
2229819 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-723929 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-584917 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2602391 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2229819 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
20756 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
14108 usd
us-gaap Interest Expense
InterestExpense
65492 usd
us-gaap Interest Expense
InterestExpense
35630 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-3475 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
18436 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-3124 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-3566 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24831 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4328 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
589917 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-39196 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-748760 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-580589 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2012474 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2269015 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-748760 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-580589 usd
us-gaap Net Income Loss
NetIncomeLoss
-2012474 usd
us-gaap Net Income Loss
NetIncomeLoss
-2269015 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-178812 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
45421 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-106555 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
79885 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-927572 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2119029 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2189130 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001134982
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-32389
dei Entity Registrant Name
EntityRegistrantName
APPLE iSPORTS GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0126444
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Spectrum Center Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 900
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
247-4210
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
208484211 shares
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
673 usd
CY2024Q3 us-gaap Deposits Assets
DepositsAssets
41513 usd
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
0 usd
CY2024Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
185410 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
166021 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
723929 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-600 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
658533 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-535168 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
208429863 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
202784211 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
206702120 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144143464 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5307174 usd
CY2024Q1 pvnc Issuance Of Common Stock Amount
IssuanceOfCommonStockAmount
647600 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
170702 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-748265 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-5237137 usd
CY2024Q2 pvnc Issuance Of Common Stock Amount
IssuanceOfCommonStockAmount
647300 usd
CY2024Q2 pvnc Stock Issuance Modification Amount
StockIssuanceModificationAmount
80000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-98445 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-515449 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-5123731 usd
CY2024Q3 pvnc Issuance Of Common Stock Amount
IssuanceOfCommonStockAmount
50000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-178812 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-748760 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-6001303 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1641763 usd
CY2023Q1 pvnc Shares Issued With Merger Amount
SharesIssuedWithMergerAmount
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
37307 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1040797 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2645253 usd
CY2023Q2 pvnc Issuance Of Common Stock Amount
IssuanceOfCommonStockAmount
100000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-2843 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-647629 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3195725 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
45421 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-580589 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-3730893 usd
us-gaap Profit Loss
ProfitLoss
-2012474 usd
us-gaap Profit Loss
ProfitLoss
-2269015 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-3124 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-15466 usd
pvnc Gain Loss Forgiveness Of Debt
GainLossForgivenessOfDebt
658533 usd
pvnc Gain Loss Forgiveness Of Debt
GainLossForgivenessOfDebt
0 usd
pvnc Non Cash Expense From Stock Issuance Modification
NonCashExpenseFromStockIssuanceModification
80000 usd
pvnc Non Cash Expense From Stock Issuance Modification
NonCashExpenseFromStockIssuanceModification
0 usd
pvnc Increase Decrease In Good And Services Tax Receivable
IncreaseDecreaseInGoodAndServicesTaxReceivable
-22369 usd
pvnc Increase Decrease In Good And Services Tax Receivable
IncreaseDecreaseInGoodAndServicesTaxReceivable
39164 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1990 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
415675 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
725685 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
60701 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
34084 usd
pvnc Increase Decrease In Accrued Payroll
IncreaseDecreaseInAccruedPayroll
236924 usd
pvnc Increase Decrease In Accrued Payroll
IncreaseDecreaseInAccruedPayroll
387299 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16120 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0 usd
pvnc Increase Decrease In Deposit
IncreaseDecreaseInDeposit
-39512 usd
pvnc Increase Decrease In Deposit
IncreaseDecreaseInDeposit
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1909836 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1145645 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
80000 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
pvnc Proceed From Advances Given To Related Party
ProceedFromAdvancesGivenToRelatedParty
0 usd
pvnc Proceed From Advances Given To Related Party
ProceedFromAdvancesGivenToRelatedParty
300 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
599371 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
970729 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1344900 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1944271 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1071029 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
51758 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64755 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6193 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9861 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
673 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19857 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6866 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9996 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1. COMPANY HISTORY AND NATURE OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Apple iSports Group, Inc. (the “Company”) was incorporated under the laws of the State of Nevada in 1975 as Vita Plus Industries, Inc. In March 1999, the Company sold its remaining inventory and changed its name to Prevention Insurance.com and effective August 31, 2023, changed its name to Apple iSports Group, Inc. Effective March 23, 2023, the Company closed a share exchange pursuant to a Stock Exchange Agreement (the “Stock Exchange Agreement”), with Apple iSports, Inc. (“AiS”), a Delaware corporation and the stockholders of AiS. Pursuant to the Stock Exchange Agreement, the Company issued to the AiS stockholders 195,062,000 shares of its common stock, par value $0.0001 per share in exchange for all of the issued and outstanding capital stock (195,062,000 shares of common stock) of AiS. AiS became a wholly-owned subsidiary of the Company. In connection with this transaction, the Company elected to change its fiscal year end from April 30 to December 31. For financial reporting purposes, the transaction is considered a combination of businesses under common control, as the Company and AiS were commonly controlled. Thus, the Company retroactively combined the results of operations and related assets and liabilities of the Company and AiS for all periods presented.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">AiS, formed on May 29, 2019, in the State of Delaware, has been engaged in the development of an online sports portal that will include racing and sports betting, fantasy sports, and sports content. On November 9, 2021, AiS incorporated Apple iSports Pty Ltd (“AIS Australia”) as a wholly owned subsidiary of AiS.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Paramount Capital Inc., was formed on September 19, 2019, in the State of Wyoming. It is a wholly-owned subsidiary of the Company and since inception, it has had limited operating activity. Effective September 19, 2024, the Company amended Paramount Capital Inc.’s name to AiSportsTek, Inc.</p>
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
195062000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 pvnc Share Issued And Outstanding For Exchange Shares
ShareIssuedAndOutstandingForExchangeShares
195062000 shares
us-gaap Net Income Loss
NetIncomeLoss
-2012474 usd
CY2024Q3 pvnc Working Capital
WorkingCapital
-6124806 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12450087 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Actual results and outcomes may differ from management’s estimates and assumptions.</p>
pvnc Shares Issued For Intellectual Property
SharesIssuedForIntellectualProperty
664011 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
658133 usd
CY2023Q4 pvnc Exchange Rate Period End
ExchangeRatePeriodEnd
0.6812 pure
CY2023Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.6640 pure
CY2024Q3 pvnc Exchange Rate Period End
ExchangeRatePeriodEnd
0.6919 pure
CY2024Q3 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.6585 pure
CY2023Q3 pvnc Exchange Rate Period End
ExchangeRatePeriodEnd
0.6431 pure
CY2023Q3 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.6550 pure
CY2024Q3 us-gaap Deposits
Deposits
41513 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
3390044 usd
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
2720549 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
142890 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
77964 usd
CY2023Q4 pvnc Due To Related Party Current
DueToRelatedPartyCurrent
4999 usd
CY2024Q3 pvnc Due To Related Party Current
DueToRelatedPartyCurrent
4999 usd
CY2024Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
21762 usd
CY2023Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
14108 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
60995 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
35630 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
208484211 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
202784211 shares
CY2024Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
50000 usd
CY2024Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
200000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
400000 shares
CY2024Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.25
CY2024Q2 pvnc Stock Issuance Modification Amount
StockIssuanceModificationAmount
80000 usd
CY2024Q2 pvnc Expensed Incremental Fair Value
ExpensedIncrementalFairValue
80000 usd
CY2024Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
647300 usd
CY2024Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2589600 shares
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
647600 usd
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2590400 shares
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
195062000 shares
CY2023Q1 pvnc Common Stock Shares Purchase Of Warrants
CommonStockSharesPurchaseOfWarrants
31000 shares
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
80000 shares
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.25
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000 usd
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
52954 usd

Files In Submission

Name View Source Status
0001477932-24-008353-index-headers.html Edgar Link pending
0001477932-24-008353-index.html Edgar Link pending
0001477932-24-008353.txt Edgar Link pending
0001477932-24-008353-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pvnc-20240930.xsd Edgar Link pending
pvnc_10q.htm Edgar Link pending
pvnc_10qimg1.jpg Edgar Link pending
pvnc_ex311.htm Edgar Link pending
pvnc_ex312.htm Edgar Link pending
pvnc_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
pvnc_10q_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pvnc-20240930_pre.xml Edgar Link unprocessable
pvnc-20240930_def.xml Edgar Link unprocessable
pvnc-20240930_lab.xml Edgar Link unprocessable
pvnc-20240930_cal.xml Edgar Link unprocessable